GLSI — Greenwich Lifesciences Share News
0.000.00%
Last trade - 00:00- $235.29m
- $226.42m
U.S. STOCKS ON THE MOVE-Autodesk, Teledyne, Alphabet
U.S. STOCKS ON THE MOVE- Medicus Pharma, Lam Research, Applied Digital
U.S. STOCKS ON THE MOVE-Micron, Rambus, GE Aerospace
Greenwich LifeSciences surges as FDA clears supplies for breast cancer trial
Brief: Greenwich Lifesciences Announces FDA Approves Use Of Commercially Manufactured Gp2 In Flamingo-01
Brief: Greenwich LifeSciences Extends Lock-Up Of Shares To September 2026
Brief: Greenwich Lifesciences Provides Global Update On Flamingo-01
Brief: Greenwich lifesciences announces addition of austria to FLAMINGO-01 clinical trial
Brief: Greenwich Lifesciences Announces Addition Of Portugal To Flamingo-01 Clinical Trial
Brief: Greenwich Lifesciences Announces Expansion Of Flamingo-01 Clinical Trial To Ireland
U.S. STOCKS ON THE MOVE-Potbelly, Joby, Talen Energy
U.S. STOCKS ON THE MOVE-Potbelly, Joby, Talen Energy
U.S. STOCKS ON THE MOVE-Waldencast, Danaher, Asset Entities
U.S. STOCKS ON THE MOVE-Nike, US chipmakers, Greenwich LifeSciences
Brief: Greenwich Lifesciences’ GLSI-100 Granted US FDA Fast Track Designation
Greenwich LifeSciences jumps on US FDA's 'fast track' tag for breast cancer therapy
Brief: Greenwich Lifesciences Announces Plan To Build Out Internal Clinical Operations Team
Greenwich Lifesciences Inc reports results for the quarter ended June 30 - Earnings Summary
Greenwich Lifesciences Inc expected to post a loss of 24 cents a share - Earnings Preview